Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1951 1
1952 3
1953 5
1954 3
1955 3
1956 8
1957 18
1958 13
1959 13
1960 10
1961 16
1962 13
1963 16
1964 9
1965 17
1966 14
1967 10
1968 7
1969 10
1970 19
1971 12
1972 18
1973 25
1974 25
1975 21
1976 21
1977 22
1978 25
1979 17
1980 26
1981 19
1982 27
1983 24
1984 28
1985 29
1986 37
1987 49
1988 52
1989 47
1990 35
1991 46
1992 46
1993 57
1994 69
1995 83
1996 88
1997 86
1998 104
1999 97
2000 117
2001 132
2002 176
2003 152
2004 208
2005 268
2006 262
2007 270
2008 339
2009 342
2010 415
2011 482
2012 493
2013 565
2014 604
2015 665
2016 682
2017 711
2018 780
2019 878
2020 1020
2021 1152
2022 1323
2023 1242
2024 681

Text availability

Article attribute

Article type

Publication date

Search Results

13,878 results

Results by year

Filters applied: . Clear all
Page 1
ThermomiR-377-3p-induced suppression of Cirbp expression is required for effective elimination of cancer cells and cancer stem-like cells by hyperthermia.
Lin TY, Jia JS, Luo WR, Lin XL, Xiao SJ, Yang J, Xia JW, Zhou C, Zhou ZH, Lin SJ, Li QW, Yang ZZ, Lei Y, Yang WQ, Shen HF, Huang SH, Wang SC, Chen LB, Yang YL, Xue SW, Li YL, Dai GQ, Zhou Y, Li YC, Wei F, Rong XX, Luo XJ, Zhao BX, Huang WH, Xiao D, Sun Y. Lin TY, et al. J Exp Clin Cancer Res. 2024 Feb 29;43(1):62. doi: 10.1186/s13046-024-02983-3. J Exp Clin Cancer Res. 2024. PMID: 38419081 Free PMC article.
CO2 Valorization in Deep Eutectic Solvents.
Guo Z, Zhang Z, Huang Y, Lin T, Guo Y, He LN, Liu T. Guo Z, et al. Among authors: lin t. ChemSusChem. 2024 Apr 17:e202400197. doi: 10.1002/cssc.202400197. Online ahead of print. ChemSusChem. 2024. PMID: 38629214 Review.
Optic neuropathy in high myopia: Glaucoma or high myopia or both?
Zhang X, Jiang J, Kong K, Li F, Chen S, Wang P, Song Y, Lin F, Lin TPH, Zangwill LM, Ohno-Matsui K, Jonas JB, Weinreb RN, Lam DSC; Glaucoma Suspects with High Myopia Study Group. Zhang X, et al. Among authors: lin tph. Prog Retin Eye Res. 2024 Mar;99:101246. doi: 10.1016/j.preteyeres.2024.101246. Epub 2024 Jan 21. Prog Retin Eye Res. 2024. PMID: 38262557 Review.
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk.
Callander NS, Silbermann R, Kaufman JL, Godby KN, Laubach J, Schmidt TM, Sborov DW, Medvedova E, Reeves B, Dhakal B, Rodriguez C, Chhabra S, Chari A, Bal S, Anderson LD Jr, Dholaria BR, Nathwani N, Hari P, Shah N, Bumma N, Holstein SA, Costello C, Jakubowiak A, Wildes TM, Orlowski RZ, Shain KH, Cowan AJ, Pei H, Cortoos A, Patel S, Lin TS, Giri S, Costa LJ, Usmani SZ, Richardson PG, Voorhees PM. Callander NS, et al. Among authors: lin ts. Blood Cancer J. 2024 Apr 22;14(1):69. doi: 10.1038/s41408-024-01030-w. Blood Cancer J. 2024. PMID: 38649340 Free PMC article. Clinical Trial.
Omics-based molecular classifications empowering in precision oncology.
Zhou Z, Lin T, Chen S, Zhang G, Xu Y, Zou H, Zhou A, Zhang Y, Weng S, Han X, Liu Z. Zhou Z, et al. Among authors: lin t. Cell Oncol (Dordr). 2024 Jun;47(3):759-777. doi: 10.1007/s13402-023-00912-8. Epub 2024 Jan 31. Cell Oncol (Dordr). 2024. PMID: 38294647 Review.
Recent Advances in Microfluidic-Based Extracellular Vesicle Analysis.
Chen J, Zheng M, Xiao Q, Wang H, Chi C, Lin T, Wang Y, Yi X, Zhu L. Chen J, et al. Among authors: lin t. Micromachines (Basel). 2024 May 8;15(5):630. doi: 10.3390/mi15050630. Micromachines (Basel). 2024. PMID: 38793203 Free PMC article. Review.
13,878 results
You have reached the last available page of results. Please see the User Guide for more information.